Nearly all participants respond to deucravacitinib in lichen planopilaris study Presented ByDr Alyssa Stockard , Mayo Clinic, AZ, USA TrialPhase 2 ConferenceAAD 2025 TypePeer-reviewed article 17 April 2025 17:55